Medtronic is a compelling investment with its diverse revenue streams, strong growth, and promising product pipeline at an ...

Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

Medtronic has been consistently growing ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based ... continuous glucose monitoring systems, and insulin pump ...

Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.

(Reuters) -Medtronic slightly lifted the lower end of its annual profit forecast on Tuesday, banking on sustained demand for its medical devices and ... continuous glucose monitor (CGM), Simplera.

Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devices that include implantable defibrillators, heart valves, insulin pumps, glucose monitoring ...

Ajizian, Medtronic’s chief medical officer of acute care and monitoring, revealed his departure on LinkedIn Thursday. The executive worked in the patient monitoring business before Medtronic ...

Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including ...

The Medtronic GI Genius™ system demonstrates AI's capacity to improve diagnostic accuracy by serving as a second set of eyes for clinicians, demonstrating 99.7%-100% sensitivity rate when screening ...